Literature DB >> 2572699

Use of auditory evoked responses as a measure of recovery from benzodiazepine sedation.

K R Milligan1, J Lumsden, R C Howard, J P Howe, J W Dundee.   

Abstract

The amplitude of the P300 component of auditory evoked responses was found to be depressed by benzodiazepine sedation and was subsequently used to monitor the recovery of volunteers sedated with midazolam. The amplitude of the evoked responses was found to be highly correlated with blood midazolam levels but to be no more sensitive than standard psychomotor testing in assessing recovery from sedation.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2572699      PMCID： PMC1292333          DOI： 10.1177/014107688908201009

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


  5 in total

1.  Flicker fusion frequency; background and applications.

Authors:  E SIMONSON; J BROZEK
Journal:  Physiol Rev       Date:  1952-07       Impact factor: 37.312

2.  Human auditory evoked potentials. II. Effects of attention.

Authors:  T W Picton; S A Hillyard
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1974-02

3.  Evoked responses--a neurophysiological indicator of depth of anaesthesia?

Authors:  P S Sebel; C P Heneghan; D A Ingram
Journal:  Br J Anaesth       Date:  1985-09       Impact factor: 9.166

4.  Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension.

Authors:  T Hedner; B Persson; G Berglund
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

5.  Enflurane anaesthesia causes graded changes in the brainstem and early cortical auditory evoked response in man.

Authors:  C Thornton; D M Catley; C Jordan; J R Lehane; D Royston; J G Jones
Journal:  Br J Anaesth       Date:  1983-06       Impact factor: 9.166
  5 in total
  6 in total

1.  Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects.

Authors:  H V Semlitsch; P Anderer; B Saletu
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  Auditory event-related potentials in panic disorder.

Authors:  A Iwanami; H Isono; Y Okajima; K Kamijima
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

3.  Effects of a small dose of triazolam on P300 and resting EEG.

Authors:  J Urata; M Uchiyama; M Iyo; T Enomoto; T Hayakawa; M Tomiyama; T Nakajima; H Sasaki; S Shirakawa; K Wada; S Fukui; H Yamadera; M Okawa
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

4.  Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects.

Authors:  M A Hotz; R Ritz; L Linder; G Scollo-Lavizzari; W E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

5.  Discriminating the effects of triazolam on stimulus and response processing by means of reaction time and P300 latency.

Authors:  E Pang; B Fowler
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

6.  Sedation for upper gastrointestinal endoscopy: a comparison of alfentanil-midazolam and meperidine-diazepam.

Authors:  M B Donnelly; W A Scott; D S Daly
Journal:  Can J Anaesth       Date:  1994-12       Impact factor: 5.063
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.